Stony Brook professor Dr. Eckard Wimmer and assistant research professor Dr. Jeronimo Cello have recently collaborated with Stony Brook University and Janssen Pharmaceuticals to develop an inactive polio vaccine based on highly attenuated polio viral seed strains.
According to the university’s press release, “These strains, when inactivated, have the potential to be as effective and as safe as the current activated poliovirus vaccine (IPV).”
Wimmer, who has been at Stony Brook for nearly forty years, is best known for his work on the poliovirus.
Last May, he was inducted into the National Academy of Science.
Sean Boykevisch, who facilitated the agreement between Janssen and the university, lauded Wimmer’s accomplishments and contributions to the field of virology, which include “the elucidation of the chemical structure of the poliovirus genome and the first in vitro synthesis of polio, or any organism for that matter.”